Reply AI Music Contest - Announced the Winner of the First International Competition Connecting AI Technologies With Music and Live Performances
7.7.2025 12:21:00 CEST | Business Wire | Press Release
Reply, an international group specialized in the creation of new business models enabled by Artificial Intelligence, is proud to announce the winner of the first edition of the Reply AI Music Contest—an international competition, organized in collaboration with the Kappa FuturFestival, aimed at creatives from around the world interested in exploring new ways to combine music, visuals, and AI technologies within live performances.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707851551/en/
The winner is the production ‘Sinvocea’ by DeLaurentis, a DJ and producer based in Paris, who incorporated AI into her electronic compositions, utilising AI-generated vocals and real-time processing. A pioneer in the use of AI in music since 2018, DeLaurentis incorporated these tools into her creative process: treating technology as an extension of her voice, she has developed a unique approach where real-time vocal improvisation generates visual shapes and colours, creating a dynamic dialogue between human and machine. Her latest work, Sinvocea, is a visual instrument that explores the intersection of sound and image, transforming performances into ephemeral moments of research and expression. By using AI to "draw" with her voice, she expands the boundaries of live performance and synesthetic creativity.
The contest, centred on the theme "Experience of a Beat", challenged artists to use AI to create immersive performances blending sound, visual art, and audience interaction. The jury — composed of Albertino, Tini Gessler, Nicola Gotti, Fleur Shore, Jacopo Di Cera, DJ Tennis, Damir Ivic, Tessa Nijdam, Heleen Blanken, Ali Demirel, Ale Lippi, Auronda Scalera & Alfredo Cramerotti, Annibale Siconolfi, and Seth Troxler — reviewed over 300 live performance projects from around the world to select five finalists.
The finalists were, I AM JAS, from Barcelona, is a DJ whose sets blend Afrobeat, techno, and experimental sound techniques, with an interest in integrating AI into live mixing; Helang, a DJ and producer based in New York, who combines techno and trance influences with a focus on digital identity and technology; Marco Puccini, a visual artist from Milan, who works with digital media and scenography, using AI tools to build responsive visual environments for live settings and the collective MIRROW, based in Turin, with their project that explores the interaction between algorithmic music generation and visual output in a live performance context
These finalists showcased their AI-integrated live sets on the LAB stage at Kappa FuturFestival, performing on Friday and Saturday from 14:00 to 15:00, with the winner announced at the close of Saturday’s event.
“I am very proud and thankful for the recognition. I used AI to produce music for many years and when the opportunity to use AI in real-time came, I took the chance to interact with the AI live, and it became a conversation between my voice and AI generated visuals, which are based on the pitch, tone, volume, speed and vibrato of the sounds I generate. As the equipment is quite complex and fragile, I tend to perform in studios, so this was the first time I performed Sinvocea on stage, in a DJ booth, and to be able to do it at Kappa FuturFestival was incredible” commented DeLaurentis, the winner of the 2025 AIMC.
“The winner and all the finalists of the Reply AI Music Contest demonstrate how Artificial Intelligence can unlock entirely new dimensions of musical expression—innovative, immersive, and deeply emotional—while preserving the human essence” said Filippo Rizzante, CTO of Reply. “Generative algorithms are reshaping the creative landscape, not only in what we produce—images, videos, sound—but in how we create. In music, we see live performances as an area with great potential from which hybrid forms will emerge, combining audio with dynamic visual elements. The Reply AI Music Contest serves as a platform to spotlight this evolution, giving emerging talents the chance to explore frontier technologies and build the skills shaping the future of music and live performance.”
At Kappa FuturFestival, we’ve always embraced innovation and creative experimentation. Partnering with Reply to host the AI Music Contest was a natural extension of our mission to push the boundaries of live performance. This collaboration allowed us to create a unique platform where technology meets artistry, demonstrating how AI can amplify emotional depth and reshape the way audiences experience music." Gianluca Brignone, Partner and Chief Innovation Officer at Kappa FuturFestival.
The AI Music Contest is part of the broader Reply Challenges, a program comprising technological and creative competitions that reflect Reply’s commitment to developing innovative educational models that engage with the younger generation. The Reply Challenges community now has over 150,000 participants worldwide.
To see more about the contest, visit aimc: https://challenges.reply.com/challenges/creative/ai-music-contest/home/
Reply
Reply [EXM, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250707851551/en/
Contacts
Press contact
Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594
Irene Caia
i.caia@reply.com
Tel. +39 02 535761
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom